The European Food Safety Authority (EFSA) should shelve plans to publish its first batch of 1024 article 13.1 health claims by the end of July until a dialogue can be opened with an increasingly apprehensive industry to clarify key aspects of the scientific...

The European Botanical Forum (EBF) says the European Union nutrition and health claims process cannot “credibly proceed” in a climate where about half of the 4000+ health claims received by the European Food Safety Authority (EFSA) have been returned...

The European Commission and European Union member states are moving to halt the flood of nutrition and health claim withdrawals in a bid to preserve what it is calling “transparency in the regulation”.

At a health claims meeting attended by regulators, politicians and regulators, held in Brussels yesterday, one of the major concerns voiced was the stifling effect on innovation the process was having.

The European Food Safety Authority (EFSA) should delay publishing the first batch of 1024 article 13.1 generic health claims due by the end of July, a meeting was told in Brussels yesterday, as industry concern about its “innovation-killing” effect reaches...

DG Sanco, the European Commission’s health and consumer protection arm, has published comments made to it by concerned parties about varying health claim opinions as they have come in from the European Food safety Authority (EFSA).

The European Food Safety Authority (EFSA) has published a Q&A (question and answer) in advance of its stakeholders meeting in Brussels on June 15, to help industry better understand the nutrition and health claims process.

In a NutraIngredients.com round table discussion, DSM’s Bas van Buijtenen expresses widespread industry concern with the EU nutrition and health claims process, while Cantox’s Nigel Baldwin tells us what we should expect from next month’s meeting with...

Are health claims dossiers really that expensive, and has the ‘wait and see’ approach to submitting dossiers won? Stephen Daniells speaks to Joerg Gruenwald, PhD, President of Analyze & Realize, about how much it costs to compile a dossier, and why...